Clinical Trial Update: Fampridine in MS Patients: A Cognition, Fatigue, Depression and Quality of Life Analysis

View source ↗

Summary

A completed clinical trial evaluating fampridine's impact on cognition, fatigue, depression, and quality of life in individuals with multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Fampridine (4-aminopyridine)

Snippet

Sponsor: Genesis Pharma CNS & Specialty | Conditions: Multiple Sclerosis | Status: COMPLETED